Carcinogenesis, Vol. 23, No. 6, 907-922,
June 2002
© 2002 Oxford University Press
REVIEW |
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
University of Minnesota Cancer Center, Minneapolis, MN 55455, USA
Measurement of human urinary carcinogen metabolites is a practical approach for obtaining important information about tobacco and cancer. This review presents currently available methods and evaluates their utility. Carcinogens and their metabolites and related compounds that have been quantified in the urine of smokers or non-smokers exposed to environmental tobacco smoke (ETS) include trans,trans-muconic acid (tt-MA) and S-phenylmercapturic acid (metabolites of benzene), 1- and 2-naphthol, hydroxyphenanthrenes and phenanthrene dihydrodiols, 1-hydroxypyrene (1-HOP), metabolites of benzo[a]pyrene, aromatic amines and heterocyclic aromatic amines, N-nitrosoproline, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides (NNAL and NNAL-Gluc), 8-oxodeoxyguanosine, thioethers, mercapturic acids, and alkyladenines. Nitrosamines and their metabolites have also been quantified in the urine of smokeless tobacco users. The utility of these assays to provide information about carcinogen dose, delineation of exposed vs. non-exposed individuals, and carcinogen metabolism in humans is discussed. NNAL and NNAL-Gluc are exceptionally useful biomarkers because they are derived from a carcinogen- 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)- that is specific to tobacco products. The NNAL assay has high sensitivity and specificity, which are particularly important for studies on ETS exposure. Other useful assays that have been widely applied involve quantitation of 1-HOP and tt-MA. Urinary carcinogen metabolite biomarkers will be critical components of future studies on tobacco and human cancer, particularly with respect to new tobacco products and strategies for harm reduction, the role of metabolic polymorphisms in cancer, and further evaluation of human carcinogen exposure from ETS.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Stepanov, P. Upadhyaya, S. G. Carmella, R. Feuer, J. Jensen, D. K. Hatsukami, and S. S. Hecht Extensive Metabolic Activation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Smokers Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1764 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. El-Zein, M. Fenech, M. S. Lopez, M. R. Spitz, and C. J. Etzel Cytokinesis-Blocked Micronucleus Cytome Assay Biomarkers Identify Lung Cancer Cases Amongst Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1111 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Stepanov and S. S. Hecht Detection and Quantitation of N'-Nitrosonornicotine in Human Toenails by Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 945 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, I. Stepanov, J. Jensen, A. Anderson, and D. K. Hatsukami Metabolism of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone to Its Biomarker Total NNAL in Smokeless Tobacco Users Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 732 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Benowitz, S. M. Hall, S. Stewart, M. Wilson, D. Dempsey, and P. Jacob III Nicotine and Carcinogen Exposure with Smoking of Progressively Reduced Nicotine Content Cigarette Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2479 - 2485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, S. E. Murphy, W. T. Riley, C. Le, X. Luo, M. Mooney, and D. K. Hatsukami Similar Exposure to a Tobacco-Specific Carcinogen in Smokeless Tobacco Users and Cigarette Smokers Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1567 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Stark, K. Rohde, J. E. Maher, B. A. Pizacani, C. W. Dent, R. Bard, S. G. Carmella, A. R. Benoit, N. M. Thomson, and S. S. Hecht The Impact of Clean Indoor Air Exemptions and Preemption Policies on the Prevalence of a Tobacco-Specific Lung Carcinogen Among Nonsmoking Bar and Restaurant Workers Am J Public Health, August 1, 2007; 97(8): 1457 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Stepanov, S. S. Hecht, B. Lindgren, P. Jacob III, M. Wilson, and N. L. Benowitz Relationship of Human Toenail Nicotine, Cotinine, and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol to Levels of These Biomarkers in Plasma and Urine Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1382 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Roethig, B. K. Zedler, R. D. Kinser, S. Feng, B. L. Nelson, and Q. Liang Short-Term Clinical Exposure Evaluation of a Second-Generation Electrically Heated Cigarette Smoking System J. Clin. Pharmacol., April 1, 2007; 47(4): 518 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Alberg, A. Kouzis, J. M. Genkinger, L. Gallicchio, A. E. Burke, S. C. Hoffman, M. Diener-West, K. J. Helzlsouer, and G. W. Comstock A Prospective Cohort Study of Bladder Cancer Risk in Relation to Active Cigarette Smoking and Household Exposure to Secondhand Cigarette Smoke Am. J. Epidemiol., March 15, 2007; 165(6): 660 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Stepanov, R. Feuer, J. Jensen, D. Hatsukami, and S. S. Hecht Mass Spectrometric Quantitation of Nicotine, Cotinine, and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in Human Toenails Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2378 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Hecht Smoking and lung cancer--a new role for an old toxicant? PNAS, October 24, 2006; 103(43): 15725 - 15726. [Full Text] [PDF]
|
|
|
|
|
|
S. G. Carmella, A. Yoder, and S. S. Hecht Combined Analysis of r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-Tetrahydrophenanthrene and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in Smokers' Plasma. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1490 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. El-Zein, M. B. Schabath, C. J. Etzel, M. S. Lopez, J. D. Franklin, and M. R. Spitz Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res., June 15, 2006; 66(12): 6449 - 6456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ding, J. Li, J. Chen, H. Chen, W. Ouyang, R. Zhang, C. Xue, D. Zhang, S. Amin, D. Desai, et al. Effects of Polycyclic Aromatic Hydrocarbons (PAHs) on Vascular Endothelial Growth Factor Induction through Phosphatidylinositol 3-Kinase/AP-1-dependent, HIF-1{alpha}-independent Pathway J. Biol. Chem., April 7, 2006; 281(14): 9093 - 9100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Avti, S. Kumar, C. M. Pathak, K. Vaiphei, and K. L. Khanduja Smokeless Tobacco Impairs the Antioxidant Defense in Liver, Lung, and Kidney of Rats Toxicol. Sci., February 1, 2006; 89(2): 547 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Carmella, S. Han, P. W. Villalta, and S. S. Hecht Analysis of Total 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in Smokers' Blood Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2669 - 2672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Hecht Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new Carcinogenesis, September 1, 2005; 26(9): 1488 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Benowitz, P. Jacob III, J. T. Bernert, M. Wilson, L. Wang, F. Allen, and D. Dempsey Carcinogen Exposure during Short-term Switching from Regular to "Light" Cigarettes Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1376 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, Y. Yan, J. Li, Q. Ma, G. D. Stoner, J. Ye, and C. Huang Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells Carcinogenesis, June 1, 2005; 26(6): 1035 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. E. Tulunay, S. S. Hecht, S. G. Carmella, Y. Zhang, C. Lemmonds, S. Murphy, and D. K. Hatsukami Urinary Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Hospitality Workers Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1283 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Stepanov and S. S. Hecht Tobacco-Specific Nitrosamines and Their Pyridine-N-glucuronides in the Urine of Smokers and Smokeless Tobacco Users Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 885 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Hecht Tobacco Carcinogen Biomarkers: Old and New Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 85 - 88. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. E. Murphy, S. G. Carmella, S. Li, J. Jensen, C. Le, A. M. Joseph, and D. K. Hatsukami Similar Uptake of Lung Carcinogens by Smokers of Regular, Light, and Ultralight Cigarettes Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 693 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kawachi More evidence on the risks of passive smoking BMJ, February 5, 2005; 330(7486): 265 - 266. [Full Text] [PDF]
|
|
|
|
|
|
H. J. Roethig, R. D. Kinser, R. W. Lau, R.-A. Walk, and N. Wang Short-Term Exposure Evaluation of Adult Smokers Switching From Conventional to First-Generation Electrically Heated Cigarettes During Controlled Smoking J. Clin. Pharmacol., February 1, 2005; 45(2): 133 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Murphy, C. A. Link, J. Jensen, C. Le, S. S. Puumala, S. S. Hecht, S. G. Carmella, L. Losey, and D. K. Hatsukami A Comparison of Urinary Biomarkers of Tobacco and Carcinogen Exposure in Smokers Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1617 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Carmella, K.-A. Le, and S. S. Hecht Improved Method for Determination of 1-Hydroxypyrene in Human Urine Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1261 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Hatsukami, C. Lemmonds, Y. Zhang, S. E. Murphy, C. Le, S. G. Carmella, and S. S. Hecht Evaluation of Carcinogen Exposure in People Who Used "Reduced Exposure" Tobacco Products J Natl Cancer Inst, June 2, 2004; 96(11): 844 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, P. M.J. Kenney, S.-H. Low, K. Arakawa, and M. C. Yu Effects of Cruciferous Vegetable Consumption on Urinary Metabolites of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Singapore Chinese Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 997 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Hughes, S S Hecht, S G Carmella, S E Murphy, and P Callas Smoking behaviour and toxin exposure during six weeks use of a potential reduced exposure product: Omni Tob. Control, June 1, 2004; 13(2): 175 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, K.-A. Le, S. E. Murphy, Y. S. Li, C. Le, J. Jensen, and D. K. Hatsukami Effects of Reduced Cigarette Smoking on Levels of 1-Hydroxypyrene in Urine Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 834 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vineis, M. Alavanja, P. Buffler, E. Fontham, S. Franceschi, Y. T. Gao, P. C. Gupta, A. Hackshaw, E. Matos, J. Samet, et al. Tobacco and Cancer: Recent Epidemiological Evidence J Natl Cancer Inst, January 21, 2004; 96(2): 99 - 106. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. E. Murphy, S. G. Carmella, C. L. Zimmerman, L. Losey, I. Kramarczuk, M. R. Roe, S. S. Puumala, Y. S. Li, C. Le, et al. Effects of Reduced Cigarette Smoking on the Uptake of a Tobacco-Specific Lung Carcinogen J Natl Cancer Inst, January 21, 2004; 96(2): 107 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, M. Chen, H. Yagi, D. M. Jerina, and S. G. Carmella r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in Human Urine: A Potential Biomarker for Assessing Polycyclic Aromatic Hydrocarbon Metabolic Activation Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1501 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Carmella, S. Han, A. Fristad, Y. Yang, and S. S. Hecht Analysis of Total 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in Human Urine Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1257 - 1261. [Abstract] [Full Text]
|
|
|
|
|
|
A B Breland, M C Acosta, and T Eissenberg Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of AdvanceTM Tob. Control, September 1, 2003; 12(3): 317 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman and W. K. Hong Cancer Prevention Science and Practice Cancer Res., September 15, 2002; 62(18): 5119 - 5125. [Full Text] [PDF]
|
|